Szanto, T.G.; Feher, A.; Korpos, E.; Gyöngyösi, A.; Kállai, J.; Mészáros, B.; Ovari, K.; Lányi, Á.; Panyi, G.; Varga, Z.
5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel. Pharmaceuticals 2023, 16, 656.
https://doi.org/10.3390/ph16050656
AMA Style
Szanto TG, Feher A, Korpos E, Gyöngyösi A, Kállai J, Mészáros B, Ovari K, Lányi Á, Panyi G, Varga Z.
5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel. Pharmaceuticals. 2023; 16(5):656.
https://doi.org/10.3390/ph16050656
Chicago/Turabian Style
Szanto, Tibor G., Adam Feher, Eva Korpos, Adrienn Gyöngyösi, Judit Kállai, Beáta Mészáros, Krisztian Ovari, Árpád Lányi, Gyorgy Panyi, and Zoltan Varga.
2023. "5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel" Pharmaceuticals 16, no. 5: 656.
https://doi.org/10.3390/ph16050656
APA Style
Szanto, T. G., Feher, A., Korpos, E., Gyöngyösi, A., Kállai, J., Mészáros, B., Ovari, K., Lányi, Á., Panyi, G., & Varga, Z.
(2023). 5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel. Pharmaceuticals, 16(5), 656.
https://doi.org/10.3390/ph16050656
